Creatine Kinase Elevation in Autosomal Dominant Polycystic Kidney Disease Patients on Tolvaptan Treatment
Conclusion: We pre sent the largest cohort that has monitored CK levels in a real-life setting, finding them elevated in 28.4% of patients. More research and monitoring will help us understand the clinical implications and the pathophysiological mechanism of CK elevation in this population.Nephron
Source: Nephron - Category: Urology & Nephrology Source Type: research
More News: Laboratory Medicine | Liver | Polycystic Kidney Disease | Spain Health | Study | Urology & Nephrology